| |
|
|
|
|
|
|
|||
|
Blood, 1 December 2008, Vol. 112, No. 12, pp. 4694-4698. Prepublished online as a Blood First Edition Paper on September 12, 2008; DOI 10.1182/blood-2008-02-136382.
Submitted February 1, 2008
H. Lee Moffitt Cancer Center and Research Institute Immunology Program, Department of Interdisciplinary Oncology, University of South Florida, Tampa, FL, United States * Corresponding author; email: pearlie.burnette{at}moffitt.org.
Large Granular lymphocyte (LGL) leukemia is commonly associated with poor hematopoiesis. The first case of pulmonary artery hypertension (PAH) was observed in a 57-year-old woman with NK-LGL leukemia and transfusion-dependent anemia. Using a genetic approach, we demonstrated that killing of pulmonary endothelial cells by patient NK-cells was mediated by dysregulated balance in activating and inhibitory NK-receptor signaling. Elevated pulmonary artery pressure and erythroid differentiation improved after disrupting the NK-receptor signaling pathway with four courses of a farnesyltransferase inhibitor tipifarnib. Coincidental association between PAH and LGL leukemia suggest a causal relationship between the expanded lymphocyte population and these clinical manifestations. This trial has been registered at www.ClinicalTrials.gov, NCI 6823
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||